Skip to main content
. Author manuscript; available in PMC: 2021 Feb 5.
Published in final edited form as: ALTEX. 2020 Feb 28;37(3):365–394. doi: 10.14573/altex.2001241

Fig. 2: Life cycle of an MPS-based assay.

Fig. 2:

Academia-driven MPS inventions are translated into qualified MPS equipment and chips by the supplier industry. Developers of all four stakeholders create MPS-based models, methods and tests. The pharmaceutical industry subsequently selects a model for a specific purpose and validates the respective MPS-based context of use assay to test safety and efficacy of novel drug candidates or advanced therapies. These data support clinical trial authorization and, consequently, final approval for use in patients.